ProCE Banner Activity

Breaking Barriers: HCV Management in People Who Use Drugs and Other Underserved Communities

Clinical Thought

Read my commentary on strategies to improve HCV management in underserved communities—including people who use drugs—through use of a same-day test-and-treat approach, colocating services, and meeting people where they are.

Released: November 26, 2024

Expiration: November 25, 2025

Share

Faculty

Mark S. Sulkowski

Mark S. Sulkowski, MD, FIDSA, FAASLD

Professor of Medicine
Director, Division of Infectious Diseases Johns Hopkins Bayview Medical Center
Johns Hopkins University School of Medicine
Baltimore, Maryland

Provided by

Provided by Clinical Care Options, LLC, in partnership with the Asian Health Foundation, Hepatitis B Foundation, and HealthHCV.

ProCE Banner

Supporters

Supported by an educational grant from Gilead Sciences, Inc.

Gilead Sciences, Inc.

Partners

AHF

ProCE Banner

Health HCV

ProCE Banner

Hepatitis B Foundation

ProCE Banner

Faculty Disclosure

Primary Author

Mark S. Sulkowski, MD, FIDSA, FAASLD

Professor of Medicine
Director, Division of Infectious Diseases Johns Hopkins Bayview Medical Center
Johns Hopkins University School of Medicine
Baltimore, Maryland

Mark S. Sulkowski, MD, FIDSA, FAASLD: consultant/advisor/speaker: AbbVie, Gilead, GlaxoSmithKline; data and safety monitoring board: Gilead.